Today: 16 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Ambev Stock Falls as Brazil Freight Crackdown Revives Cost Risk

Ambev Stock Falls as Brazil Freight Crackdown Revives Cost Risk

Ambev shares trading in the U.S. slipped 0.9% to finish at $2.80 on Thursday. The move came after Brazil’s government included the brewer on a list of companies fined for violating minimum freight-price rules—a mandatory floor for trucking rates—and said that repeat violations could trigger bans on hiring freight. Ambev’s shares in São Paulo had already dropped 1.9% on Wednesday, closing at 14.74 reais.
19 March 2026
Oil Prices Surge as Brent Briefly Tops $119 After Gulf Strikes, WTI Lags on Supply Moves

Oil Prices Surge as Brent Briefly Tops $119 After Gulf Strikes, WTI Lags on Supply Moves

Oil prices whipsawed Thursday as Iran struck energy sites throughout the Gulf. Brent crude surged as high as $119 a barrel, then slid back, changing hands at $108.46 by 12:39 p.m. CDT. U.S. West Texas Intermediate hit $100.02 before settling at $96.77. Meanwhile, Dubai and Oman crude premiums set fresh records, approaching $65 a barrel. “This pullback from the highs suggests the market has gained more confidence in supply,” said Phil Flynn at Price Futures Group.
19 March 2026
Mortgage Rates Today Jump to 3-Month High as 30-Year Fixed Hits 6.22%, Homebuilder Stocks Slip

Mortgage Rates Today Jump to 3-Month High as 30-Year Fixed Hits 6.22%, Homebuilder Stocks Slip

The 30-year fixed-rate mortgage in the U.S. climbed to 6.22% this week—marking its highest point since early December—driven by a jump in Treasury yields that filtered into consumer borrowing. Last week, Freddie Mac had the rate at 6.11%. A year ago, it stood at 6.67%. For borrowers opting for a 15-year fixed, the average ticked up to 5.54%, compared with 5.50% last week.
19 March 2026
Dow Jones Today: Index Slides Again as Oil Tops $119 and Fed Cut Hopes Fade

Dow Jones Today: Index Slides Again as Oil Tops $119 and Fed Cut Hopes Fade

Dow Jones Industrial Average slid 427.99 points, or 0.92%, to 45,797.70 by 11:36 a.m. ET Thursday, as rising crude and a hawkish Fed put investors on edge. The S&P 500 lost 0.77%, with the Nasdaq Composite down 0.93%. Russell 2000 briefly slipped into correction—10% off its highs. All three benchmarks traded below the 200-day moving average, a key momentum gauge. Micron dropped 4.1%; Nvidia slipped 1.2%.
US Stock Market Today: Dow, S&P 500, Nasdaq Slide as Oil Spike Hits Rate-Cut Hopes

US Stock Market Today: Dow, S&P 500, Nasdaq Slide as Oil Spike Hits Rate-Cut Hopes

Stocks stumbled on Thursday, with the Dow shedding about 460 points by midday. The S&P 500 and Nasdaq each slipped between 0.8% and 1% as a fresh surge in oil sent traders fleeing risk. Brent crude spiked above $119 a barrel early before pulling back toward $112. Over in small caps, the Russell 2000 dipped to a level 10% under its Jan. 22 high—a threshold many watchers use to mark a correction.
Nexstar-Tegna Merger Hit by 8-State Lawsuit, Threatening $6.2 Billion TV Deal

Nexstar-Tegna Merger Hit by 8-State Lawsuit, Threatening $6.2 Billion TV Deal

California, along with seven other states, filed suit late Wednesday aiming to halt Nexstar Media Group’s $6.2 billion deal for Tegna, a move that would vault Nexstar to the top spot among local TV station owners in the U.S. In a complaint lodged in federal court in Sacramento, the states argue the merger threatens to boost pay-TV prices and erode local news coverage by folding competing stations under one operator.
1 171 172 173 174 175 882

Stock Market Today

  • AstraZeneca (LSE:AZN) Seen Undervalued Against Cash Flow Estimates
    July 16, 2026, 11:08 AM EDT. AstraZeneca (LSE:AZN) looks undervalued on discounted cash flow, even with its $60.4 billion in revenue and a wide drug lineup. Analysts point to a solid oncology and specialty medicines pipeline, with newer assets like Zegfrovy, Enhertu, and TRUQAP expected to add to future sales. Risks are there-heavy R&D spend, high debt, and blockbuster drug pressures. Still, some say the current share price isn't pricing in the cash flow outlook, and value-focused investors may see an opportunity around long-term cash returns.
Go toTop